Method of vaccination for prevention of Bordetella bronchiseptic

Drug – bio-affecting and body treating compositions – Whole live micro-organism – cell – or virus containing – Genetically modified micro-organism – cell – or virus

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

206510, A61K 3910

Patent

active

045308322

ABSTRACT:
Viable cells of an avirulent self-clearing strain of B. bronchiseptica are administered as an intra-respiratory vaccine. An aqueous suspension of the cells is applied to the respiratory mucosa immediately after incorporating a non-inhibitory amount of a wetting agent promoting the mucosal implantation of the cells. Effective immunization can thereby be obtained against diseases such as kennel cough in dogs and atrophic rhinitis in swine even through the strain of B. bronchiseptica is so highly attenuated that it is self-clearing from the respiratory mucosa.

REFERENCES:
patent: 3384544 (1968-05-01), Walton et al.
patent: 3567585 (1971-03-01), Bloch et al.
patent: 3607858 (1971-09-01), Querry et al.
patent: 4225583 (1980-09-01), Switzer et al.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Method of vaccination for prevention of Bordetella bronchiseptic does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Method of vaccination for prevention of Bordetella bronchiseptic, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of vaccination for prevention of Bordetella bronchiseptic will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-634148

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.